Health Care & Life Sciences » Biotechnology | Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc. A | Mutual Funds

Mutual Funds that own Hualan Biological Engineering Inc. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
14,679,856
1.83%
14,079,784
4.47%
12/31/2017
E Fund Middle & Small Cap. Equity Fund
8,400,003
1.05%
4,400,000
6.49%
12/31/2017
Yinhua Prosperity Theme Equity Fund
3,672,423
0.46%
1,156,305
1.84%
12/31/2017
2,968,040
0.37%
2,968,040
5.34%
12/31/2017
Fidelity Funds SICAV - South East Asia Fund
2,923,589
0.36%
12
0.66%
05/31/2018
Fidelity Institutional Funds - Emerging Markets Fund
2,761,098
0.34%
-293,000
0.45%
05/31/2018
Government Pension Fund - Global (The)
2,137,988
0.27%
2,137,988
0%
12/31/2017
E Fund Value Growth
1,814,800
0.23%
1,814,800
1.07%
12/31/2017
1,467,292
0.18%
1,275,832
1.88%
12/31/2017
1,461,945
0.18%
-1,034,476
1.59%
12/31/2017

About Hualan Biological Engineering

View Profile
Address
No. 1 Hualan Avenue
Xinxiang Henan 453003
China
Employees -
Website http://www.hualanbio.com
Updated 07/08/2019
Hualan Biological Engineering, Inc. engages in the manufacture, production, commercialization, research and development of biopharmaceutical products. It focuses on human blood products, viral vaccines, bacterial vaccines and recombinant biologics. The company was founded on March 20, 1992 and is headquartered in Xinxiang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.